Astero Klabatsa

541 total citations
13 papers, 425 citations indexed

About

Astero Klabatsa is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Cancer Research. According to data from OpenAlex, Astero Klabatsa has authored 13 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Biotechnology and 4 papers in Cancer Research. Recurrent topics in Astero Klabatsa's work include Occupational and environmental lung diseases (7 papers), Cancer Research and Treatments (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Astero Klabatsa is often cited by papers focused on Occupational and environmental lung diseases (7 papers), Cancer Research and Treatments (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Astero Klabatsa collaborates with scholars based in United Kingdom, United States and Australia. Astero Klabatsa's co-authors include Jeremy Steele, Michael Sheaff, Robin Rudd, Dean A. Fennell, Marie T. Evans, Tim Crook, Frances R. Balkwill, Peter W. Szlosarek, Paul Smith and Dean A. Fennell and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Astero Klabatsa

13 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astero Klabatsa United Kingdom 9 283 129 87 71 49 13 425
Paul Hachem United States 12 191 0.7× 28 0.2× 135 1.6× 55 0.8× 111 2.3× 20 331
Biao He United States 10 188 0.7× 24 0.2× 172 2.0× 78 1.1× 106 2.2× 13 370
S.M. Jamshedur Rahman United States 3 84 0.3× 45 0.3× 197 2.3× 56 0.8× 170 3.5× 4 299
Blaž Grošelj Slovenia 12 67 0.2× 22 0.2× 296 3.4× 56 0.8× 131 2.7× 19 439
Jean Pascal Machiels United States 3 72 0.3× 19 0.1× 105 1.2× 43 0.6× 114 2.3× 3 262
Marta Vaz Batista Portugal 7 187 0.7× 10 0.1× 81 0.9× 51 0.7× 270 5.5× 28 358
Gareth Rivalland Australia 10 98 0.3× 18 0.1× 78 0.9× 21 0.3× 112 2.3× 26 248
Prabir Chakravarty United States 7 53 0.2× 18 0.1× 98 1.1× 34 0.5× 216 4.4× 22 359
Nobuhiro Torata Japan 12 43 0.2× 15 0.1× 145 1.7× 52 0.7× 150 3.1× 26 325
Jack Zhu United States 6 97 0.3× 8 0.1× 107 1.2× 83 1.2× 72 1.5× 10 230

Countries citing papers authored by Astero Klabatsa

Since Specialization
Citations

This map shows the geographic impact of Astero Klabatsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astero Klabatsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astero Klabatsa more than expected).

Fields of papers citing papers by Astero Klabatsa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astero Klabatsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astero Klabatsa. The network helps show where Astero Klabatsa may publish in the future.

Co-authorship network of co-authors of Astero Klabatsa

This figure shows the co-authorship network connecting the top 25 collaborators of Astero Klabatsa. A scholar is included among the top collaborators of Astero Klabatsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astero Klabatsa. Astero Klabatsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Busacca, Sara, Ian Powley, David A. Proia, et al.. (2015). Resistance to HSP90 inhibition involving loss of MCL1 addiction. Oncogene. 35(12). 1483–1492. 24 indexed citations
2.
Barbone, Dario, Carlo Follo, N Echeverry, et al.. (2015). Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS ONE. 10(8). e0134825–e0134825. 12 indexed citations
3.
Busacca, Sara, Astero Klabatsa, Ken Arthur, et al.. (2013). BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma. PLoS ONE. 8(6). e65489–e65489. 13 indexed citations
4.
Armato, Samuel G., Zacariah E. Labby, Johan Coolen, et al.. (2013). Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 82(2). 190–196. 27 indexed citations
5.
Klabatsa, Astero, Sugama Chicklore, Sally F. Barrington, et al.. (2013). The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma. European Journal of Nuclear Medicine and Molecular Imaging. 41(2). 276–282. 44 indexed citations
6.
Busacca, Sara, Astero Klabatsa, Ken Arthur, et al.. (2013). Correction: BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma. PLoS ONE. 8(12). 1 indexed citations
7.
Szlosarek, Peter W., Astero Klabatsa, Michael Sheaff, et al.. (2006). In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion. Clinical Cancer Research. 12(23). 7126–7131. 150 indexed citations
8.
Steele, Jeremy & Astero Klabatsa. (2005). Chemotherapy options and new advances in malignant pleural mesothelioma. Annals of Oncology. 16(3). 345–351. 51 indexed citations
9.
Klabatsa, Astero, Michael Sheaff, Jeremy Steele, et al.. (2005). Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM). Lung Cancer. 51(1). 53–59. 48 indexed citations
10.
Steele, Jeremy, Astero Klabatsa, Dean A. Fennell, et al.. (2005). Prognostic factors in mesothelioma. Lung Cancer. 49. S49–S52. 48 indexed citations
11.
Klabatsa, Astero, M. Sheaff, Jeremy Steele, et al.. (2004). Identification of glucose transporter type 1 overexpression as a predictor of survival in patients with malignant pleural mesothelioma. Journal of Clinical Oncology. 22(14_suppl). 7199–7199. 2 indexed citations
12.
Klabatsa, Astero, Michael Sheaff, Jeremy Steele, et al.. (2004). Identification of glucose transporter type 1 overexpression as a predictor of survival in patients with malignant pleural mesothelioma. Journal of Clinical Oncology. 22(14_suppl). 7199–7199. 4 indexed citations
13.
Fennell, Dean A., Astero Klabatsa, Michael Sheaff, et al.. (2003). P-516 Expression and prognostic significance of hypoxia-inducible factor 1 alpha in malignant pleural mesothelioma. Lung Cancer. 41. S221–S221. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Hachem Breakdown of academic impact, for papers by Biao He Breakdown of academic impact, for papers by S.M. Jamshedur Rahman Breakdown of academic impact, for papers by Blaž Grošelj Breakdown of academic impact, for papers by Jean Pascal Machiels Breakdown of academic impact, for papers by Marta Vaz Batista Breakdown of academic impact, for papers by Gareth Rivalland Breakdown of academic impact, for papers by Prabir Chakravarty Breakdown of academic impact, for papers by Nobuhiro Torata Breakdown of academic impact, for papers by Jack Zhu
Rankless by CCL
2026